Corcept Therapeutics Officer Awarded 100,000 Stock Options
CORCEPT THERAPEUTICS INC
Subscribe to track CORT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Insider Grant: Corcept Therapeutics Inc ($CORT) ā¢ Insider: Justin Frederick Gunn (President, Corcept Endocrinology) ā¢ Transaction: Award of 100,000 Stock Options at an exercise price of $114.025 ā¢ Date: 2026-10-01 ā¢ Total Shares Owned Post-Transaction: 100,000 options ā¢ Significance: Low (Routine equity award)
Comprehensive Analysis
Executive Compensation Overview
On October 1, 2026, Justin Frederick Gunn, President of Corcept Endocrinology at Corcept Therapeutics Inc ($CORT), received an award of 100,000 stock options (right to buy) under transaction code A (Award/Grant).
Key Transaction Details:
- Security: Stock Option (right to buy)
- Underlying Shares: 100,000 shares of Common Stock
- Exercise Price: $114.025 per share
- Expiration Date: October 1, 2036
- Vesting Schedule: Exercisable ratably in equal installments on each monthly anniversary of October 1, 2026 over a four-year period, contingent on continued service.
Market & Trading Implications:
Because this transaction represents a standard compensatory stock option grant rather than an open-market purchase or sale, it does not directly reflect immediate insider buying conviction or capital outlay. As such, the trading significance is rated Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.